Fard-Aghaie Mohammad, Stavrou Gregor A, Honarpisheh Human, Niehaus Klaus J, Oldhafer Karl J
Department of General and Abdominal Surgery, Asklepios Hospital Barmbek, Ruebenkamp 220, 22291, Hamburg, Germany.
Semmelweis University Budapest, Campus Hamburg, Hamburg, Germany.
World J Surg Oncol. 2015 Aug 28;13:261. doi: 10.1186/s12957-015-0675-6.
In 1942, Stout described tumors which derive from Zimmerman's pericytes and suggested the term hemangiopericytoma (HPC). These tumors, which are often highly vascularized, pose difficulties in the surgical management regarding blood loss and complete resection. Therefore, preoperative management seems to be an essential part in dealing with these issues.
We present a 70-year-old female patient with a large HPC in the pelvis. Preoperative embolization of the tumor was performed, and 2 weeks after the intervention, we completely resected the tumor with minimal blood loss.
In which cases do we need preoperative treatment, especially emboliziation of hemangiopericytomas/solid fibrous tumors (SFT)? Although preoperative embolizations of tumors are now commonly undertaken, as for now, neither a clear statement nor a standardized approach has been given or developed. The purpose of this article is to provide our experience with preoperative embolization and to start a new discussion concerning a standardized approach.
1942年，斯托特描述了起源于齐默尔曼周细胞的肿瘤，并提出了血管外皮细胞瘤（HPC）这一术语。这些肿瘤通常血管高度丰富，在手术治疗中因失血和完整切除方面存在困难。因此，术前管理似乎是处理这些问题的关键部分。
我们报告一名70岁骨盆部患有巨大血管外皮细胞瘤的女性患者。对肿瘤进行了术前栓塞，干预2周后，我们以最小的失血量完整切除了肿瘤。
我们在哪些情况下需要术前治疗，尤其是血管外皮细胞瘤/实性纤维性肿瘤（SFT）的栓塞治疗？尽管目前肿瘤的术前栓塞治疗很常见，但到目前为止，既没有给出明确的说法，也没有制定出标准化的方法。本文的目的是分享我们术前栓塞治疗的经验，并开启关于标准化方法的新讨论。
